Subscribe to Daily Review - your favourite M&A deals update.

MergerLinks Header Logo

Submit Deal

Submit Deal

Cover Image Tim Opler
Tim OplerStifel

Tim Opler

Managing Director and Co-Founder at Stifel

Financial Advisor

Deal Bio

Total Deals13
Valued Deals5
Total Value£ 516 M
Avg. Deal Size£ 103 M

Market Context

Sort

13 Jan 2025|United States|Biotechnology
Imaginab (therapeutic Assets And Biologics Technology Platform)
Telix Pharmaceuticals

Target: IMAGINAB (THERAPEUTIC ASSETS AND BIOLOGICS TECHNOLOGY PLATFORM)

Bidder: TELIX PHARMACEUTICALS

4 Service Providers

1 Bidder | 3 Vendor

9 Dealmakers

2 Bidder | 7 Vendor

£ 185 M

Value

24 Jul 2024|United States|Pharmaceuticals
Palvella Therapeutics
Pieris Pharmaceuticals

Target: PALVELLA THERAPEUTICS

Bidder: PIERIS PHARMACEUTICALS

6 Service Providers

3 Target | 3 Bidder

8 Dealmakers

2 Target | 6 Bidder

n/a

Value

11 Jun 2024|Chile|Software
Neuralis
Gedeon Richter

Target: NEURALIS SA

Bidder: GEDEON RICHTER

4 Service Providers

2 Bidder | 2 Vendor

31 Dealmakers

6 Bidder | 25 Vendor

£ 147 M

Value

09 Apr 2024|United States|Biotechnology
Beacon Therapeutics (contract, Manufacturing And Controls Team)
Ascend Advanced Therapies

Target: BEACON THERAPEUTICS (CONTRACT, MANUFACTURING AND CONTROLS TEAM)

Bidder: ASCEND ADVANCED THERAPIES

5 Service Providers

3 Bidder | 2 Vendor

9 Dealmakers

5 Bidder | 4 Vendor

n/a

Value

09 Jan 2024|United States|Medical Equipment
Lantheus (somerset Facility)
Perspective Therapeutics

Target: LANTHEUS (SOMERSET FACILITY)

Bidder: PERSPECTIVE THERAPEUTICS

4 Service Providers

2 Bidder | 2 Vendor

12 Dealmakers

4 Bidder | 8 Vendor

n/a

Value

29 Nov 2023|Denmark|Pharmaceuticals
Ascendis Pharma As
Teijin

Target: ASCENDIS PHARMA AS

Bidder: TEIJIN LIMITED

4 Service Providers

2 Target | 2 Bidder

9 Dealmakers

3 Target | 6 Bidder

£ 55 M

Value

24 Oct 2023|United States|Pharmaceuticals
Infirst Usa Holdings
Carlin Consumer Health

Target: INFIRST USA HOLDINGS

Bidder: CARLIN CONSUMER HEALTH

6 Service Providers

3 Target | 3 Bidder

8 Dealmakers

6 Target | 2 Bidder

n/a

Value

20 Sep 2023|United States|Biotechnology
Kezar Life Sciences
Everest Medicines

Target: KEZAR LIFE SCIENCES

Bidder: EVEREST MEDICINES LTD

3 Service Providers

2 Target | 1 Bidder

6 Dealmakers

4 Target | 2 Bidder

£ 106 M

Value

30 Jul 2023|Ireland|Pharmaceuticals
Nabriva Therapeutics
Sumitomo Pharma

Target: NABRIVA THERAPEUTICS PLC

Bidder: SUMITOMO PHARMA

2 Service Providers

1 Target | 1 Bidder

5 Dealmakers

4 Target | 1 Bidder

n/a

Value

15 May 2023|China|Pharmaceuticals
Lanova Medicines
Astrazeneca

Target: LANOVA MEDICINES

Bidder: ASTRAZENECA PLC

2 Service Providers

2 Target

4 Dealmakers

4 Target

n/a

Value

23 Feb 2023|United States|Biotechnology
Mei Pharma
Infinity Pharmaceuticals

Target: MEI PHARMA

Bidder: INFINITY PHARMACEUTICALS

8 Service Providers

4 Target | 4 Bidder

12 Dealmakers

10 Target | 2 Bidder

n/a

Value

10 Feb 2023|Germany|Biotechnology
Freeline Therapeutics (german Subsidiary)
Ascend Gene And Cell Therapies

Target: FREELINE THERAPEUTICS (GERMAN SUBSIDIARY)

Bidder: ASCEND GENE AND CELL THERAPIES

3 Service Providers

1 Bidder | 2 Vendor

7 Dealmakers

1 Bidder | 6 Vendor

£ 20 M

Value

22 Dec 2022|United States|Investment Banking
Torreya Partners
Stifel Financial Corp

Target: TORREYA PARTNERS

Bidder: STIFEL FINANCIAL CORP

6 Service Providers

4 Target | 2 Bidder

24 Dealmakers

19 Target | 5 Bidder

n/a

Value

Privacy PolicyTerms of ServiceContact UsCookie Preferences

All rights reserved. Copyright © 2025 Datasite